A study by Pfizer and a university in Texas found that the vaccine developed by the company is also effective against mutations in the corona virus found in the UK and South Africa.
In the study, 20 blood samples were taken from people who had received the Pfizer-Biontech vaccine. The antibodies developed in these people successfully repelled the virus.
Dr. Philip Dormitzer, Pfizer’s chief scientist, said “it is very encouraging that at least this mutation that worries many in the world does not seem like a problem.”
The antibodies identified in the blood taken from the patients were able to fight the mutation in Petri dishes in the laboratories. The study has not yet been thoroughly reviewed by experts.
About 1.7 million Israelis have already been vaccinated with the first dose of Pfizer’s vaccine. 7,597 people were infected with the corona virus yesterday, and the rate of positive tests was 6.2%. The hospitals currently house 873 patients in Corona whose condition is severely defined.
Health Minister Yuli Edelstein said that “tomorrow I would be happy to be the second Israeli to receive a second dose of vaccine, on the way to being released from the damn virus.”
Prime Minister Benjamin Netanyahu announced last night that he had reached an agreement with the CEO of the pharmaceutical giant Pfizer, according to which all Israeli citizens over the age of 16 will be vaccinated by the end of March. The vaccinated family, “Netanyahu said.